Výsledky vyhledávání

Akademický článek

Metabolic Plasticity Is an Essential Requirement of Acquired Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia.

Autor: Mostazo MGC; Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, Universitat de Barcelona, 08028 Barcelona, Spain.; Institute of Biomedicine of University of Barcelona, 08028 Barcelona, Spain.; Department of Medicine, Hematology/Oncology, University Hospital Frankfurt, Goethe-University, 60590 Frankfurt am Main, Germany., Kurrle N; Department of Medicine, Hematology/Oncology, University Hospital Frankfurt, Goethe-University, 60590 Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, 60590 Frankfurt am Main, Germany., Casado M; Biomedicine Institute of Valencia, IBV-CSIC, 46010 Valencia, Spain.; CIBER of Hepatic and Digestive Diseases (CIBEREHD), Institute of Health Carlos III (ISCIII), 28029 Madrid, Spain., Fuhrmann D; Institute of Biochemistry I, Faculty of Medicine, Goethe-University Frankfurt, 60590 Frankfurt am Main, Germany., Alshamleh I; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Center for Biomolecular Magnetic Resonance, Institute of Organic Chemistry and Chemical Biology, Goethe-University, 60438 Frankfurt am Main, Germany., Häupl B; Department of Medicine, Hematology/Oncology, University Hospital Frankfurt, Goethe-University, 60590 Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, 60590 Frankfurt am Main, Germany., Martín-Sanz P; CIBER of Hepatic and Digestive Diseases (CIBEREHD), Institute of Health Carlos III (ISCIII), 28029 Madrid, Spain.; 'Alberto Sols' Biomedical Research Institute, CSIC-UAM, 28029 Madrid, Spain., Brüne B; Frankfurt Cancer Institute (FCI), Goethe University, 60590 Frankfurt am Main, Germany.; Institute of Biochemistry I, Faculty of Medicine, Goethe-University Frankfurt, 60590 Frankfurt am Main, Germany.; Project Group Translational Medicine and Pharmacology TMP, Fraunhofer Institute for Molecular Biology and Applied Ecology, 60596 Frankfurt am Main, Germany., Serve H; Department of Medicine, Hematology/Oncology, University Hospital Frankfurt, Goethe-University, 60590 Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, 60590 Frankfurt am Main, Germany., Schwalbe H; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Center for Biomolecular Magnetic Resonance, Institute of Organic Chemistry and Chemical Biology, Goethe-University, 60438 Frankfurt am Main, Germany., Schnütgen F; Department of Medicine, Hematology/Oncology, University Hospital Frankfurt, Goethe-University, 60590 Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, 60590 Frankfurt am Main, Germany., Marin S; Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, Universitat de Barcelona, 08028 Barcelona, Spain.; Institute of Biomedicine of University of Barcelona, 08028 Barcelona, Spain.; CIBER of Hepatic and Digestive Diseases (CIBEREHD), Institute of Health Carlos III (ISCIII), 28029 Madrid, Spain.; Metabolomics Node at Spanish National Bioinformatics Institute (INB-ISCIII-ES- ELIXIR), Institute of Health Carlos III (ISCIII), 28029 Madrid, Spain., Cascante M; Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, Universitat de Barcelona, 08028 Barcelona, Spain.; Institute of Biomedicine of University of Barcelona, 08028 Barcelona, Spain.; CIBER of Hepatic and Digestive Diseases (CIBEREHD), Institute of Health Carlos III (ISCIII), 28029 Madrid, Spain.; Metabolomics Node at Spanish National Bioinformatics Institute (INB-ISCIII-ES- ELIXIR), Institute of Health Carlos III (ISCIII), 28029 Madrid, Spain.

Publikováno v: Cancers [Cancers (Basel)] 2020 Nov 19; Vol. 12 (11). Date of Electronic Publication: 2020 Nov 19.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Inducers of salmon innate immunity: An in vitro and in vivo approach.

Autor: Estévez RA; Stofnfiskur Staðarberg 2-4, 221 Hafnarfjörður, Iceland; Institute of Life and Environmental Sciences, University of Iceland, Sturlugata 7, 101 Reykjavik, Iceland., Mostazo MGC; Stofnfiskur Staðarberg 2-4, 221 Hafnarfjörður, Iceland; Institute of Life and Environmental Sciences, University of Iceland, Sturlugata 7, 101 Reykjavik, Iceland., Rodriguez E; Stofnfiskur Staðarberg 2-4, 221 Hafnarfjörður, Iceland., Espinoza JC; Centro de Investigación y Gestión de Recursos Naturales, Instituto de Química y Bioquímica, Facultad de Ciencias, Universidad de Valparaíso, Gran Bretaña 1111, Valparaíso 2360102, Chile., Kuznar J; Centro de Investigación y Gestión de Recursos Naturales, Instituto de Química y Bioquímica, Facultad de Ciencias, Universidad de Valparaíso, Gran Bretaña 1111, Valparaíso 2360102, Chile., Jónsson ZO; Institute of Life and Environmental Sciences, University of Iceland, Sturlugata 7, 101 Reykjavik, Iceland; Biomedical Center, University of Iceland, Vatnsmýrarvegur 16, 101 Reykjavik, Iceland., Guðmundsson GH; Institute of Life and Environmental Sciences, University of Iceland, Sturlugata 7, 101 Reykjavik, Iceland; Biomedical Center, University of Iceland, Vatnsmýrarvegur 16, 101 Reykjavik, Iceland., Maier VH; Biomedical Center, University of Iceland, Vatnsmýrarvegur 16, 101 Reykjavik, Iceland. Electronic address: valerie@hi.is.

Publikováno v: Fish & shellfish immunology [Fish Shellfish Immunol] 2018 Jan; Vol. 72, pp. 247-258. Date of Electronic Publication: 2017 Nov 08.

Zobrazit plný text záznamu

Akademický článek

Metabolomics for hematologic malignancies: Advances and perspective.

Autor: Li X; Linyi People's Hospital, Shandong Second Medical University, Linyi, PR China., Xu M; Linyi People's Hospital, Shandong Second Medical University, Linyi, PR China., Chen Y; Hematology Laboratory, Linyi People's Hospital, Linyi, PR China., Zhai Y; Department of Orthopedics, Linyi People's Hospital, Linyi, PR China., Li J; Linyi People's Hospital, Shandong Second Medical University, Linyi, PR China., Zhang N; Department of Anesthesiology, Linyi People's Hospital, Linyi, PR China., Yin J; Central Laboratory, Linyi People's Hospital, Linyi, PR China.; Key Laboratory of Tumor Biology, Linyi, PR China.; Key Laboratory for Translational Oncology, Xuzhou Medical University, Xuzhou, PR China., Wang L; Central Laboratory, Linyi People's Hospital, Linyi, PR China.; Key Laboratory of Tumor Biology, Linyi, PR China.; Key Laboratory for Translational Oncology, Xuzhou Medical University, Xuzhou, PR China.; Department of Hematology, Linyi People's Hospital, Linyi, PR China.

Publikováno v: Medicine [Medicine (Baltimore)] 2024 Sep 20; Vol. 103 (38), pp. e39782.

Zobrazit plný text záznamu